Skip to main content

Table 1 Model parameters point estimate values and ranges

From: Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Parameter

Point estimate

Plausible Range

Distribution

Reference

Treatment efficacy (success rate, %)

   
 

Fluconazole

63.0

57.0–74.0

Beta

Mills et al., 2009 [21]

 

Caspofungin

76.1

63.6–78.0

Beta

Mills et al., 2009 [21]

 

L-AmB

72.9

66.4–76.0

Beta

Mills et al., 2009 [21]

Mortality rate (%)

    
 

Fluconazole

28.4

16.6–31.4

Beta

Mills et al., 2009 [21]

 

Caspofungin

33.8

26.4–34.2

Beta

Mills et al., 2009 [21]

IC/C recurrence rate (%)

4.4

1.4–13.0

Beta

Ásmundsdóttir et al., 2012; Muñoz et al., 2016; Reboli et al.,2007; Pappas et al., 2007

[20, 22, 27, 28]

Utilities

    
 

Patient with IC/C

0.72

0.50–0.94

Beta

CEA Registry, Tufts Medical Center [25]

 

Healthy or survivors

0.94

0.84–0.94

Beta

Granja et al., 2004; Welie et al., 2020 [24, 26]

Costs (US$)

    
 

Loading dose cost

    
  

Fluconazole 800 mg per day

$3

$2–5

Gamma

TASH and MCM

  

Caspofungin 70 mg per day

$179

$150–200

Gamma

MCM

  

L-AmB (3 mg/kg per day for an average weight of 70 kg)

$198

$190–215

Gamma

TASH and MCM

 

Maintenance dose

    
  

Fluconazole 400 mg per day

$17

$15–30

Gamma

TASH and MCM

  

Caspofungin 50 mg per day

$2322

$2000–2500

Gamma

MCM

  

L-AmB (3 mg/kg per day for an average weight of 70 kg)

$2574

$500–2,700

Gamma

TASH and MCM

 

Hospitalization cost per day

$5

$1–35

Gamma

TASH and MCM

 

Diagnostic and monitoring costs

$76

$50–100

Gamma

TASH and MCM

  1. TASH: Tikur Anbesa Specialized Hospital; MCM: Myung Sung Christian Medical General Hospital